Director, Epidemiology
Johnson & Johnson
Dr. Krumme is a Director of Epidemiology in the immunology therapeutic area at Johnson & Johnson Innovative Medicine. She holds a doctorate in pharmacoepidemiology and has over 10 years of career experience leading drug safety studies. Prior to J&J, she was at Vertex Pharmaceuticals and the Brigham and Women's Hospital in the Division of Pharmacoepidemiology and Pharmacoeconomics.